For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Cipla subsidiary acquires Celeris

|

Pharma major, Cipla in a notice to the Bombay Stock Exchange has said that Cipla Holding B.V., a wholly owned subsidiary of the Company, has acquired 100 per cent stake in Celeris d.o.o., Croatia.

Celeris d.o.o. is the distributor of Company's products in Croatia. Cipla Ltd is one of the world's largest generic companies. The company has over 2,000 products, 65 therapeutic categories, over 40 dosage forms. The company has 34 state-of-the-art manufacturing facilities approved by major international regulatory agencies.

 

The stock of Cipla was trading marginally higher at Rs 393 on the Bombay Stock Exchange.

GoodReturns.in

Read more about: cipla celeris
Story first published: Thursday, December 5, 2013, 10:33 [IST]
Company Search
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more